DP
Devang Parikh
Also known as: Parikh DP
Glenmark Pharmaceuticals (India), Intas Pharmaceuticals Ltd, Sumandeep Vidyapeeth University, Gujarat University, Wockhardt Ltd
0000-0002-5789-9630
Employment
-
Glenmark Pharmaceuticals (India) Clinical Lead2022 - Present
-
Intas Pharmaceuticals Ltd Clinical Lead2019 - 2022
-
Wockhardt Ltd Medical Monitor, Writer2018 - 2019
-
SAVA Healthcare Limited Medical Adviser2017 - 2018
-
Zydus Cadila Associate Research Scientist2014 - 2017
Education
-
Sumandeep Vidyapeeth University MD2011 - 2014
-
Gujarat University MBBS2004 - 2010
Projects & Funding
Projects & funding information is unavailable.
Publications (14)
- Blood and Blood-Derived Products Save
- Safety and efficacy of COVID-19 hyperimmune globulin (HIG) solution in the treatment of active COVID-19 infection- Findings from a Prospective, Randomized, Controlled, Multi-Centric Trial Save
- THE CLINICAL SCENARIO AND PHARMACOTHERAPY OF RESPIRATORY DISEASES IN PEDIATRIC PATIENTS Save
- Role of Anti-COVID-19 antibody testing in the management of pandemic Save
- ROLE OF HOMOEOPATHY IN COVID-19 MANAGEMENT-A CLINICAL EXPERIENCE Save
- An Industry Perspective on Risks and Mitigation strategies Associated with Post Conduct Phase of Clinical Trial Save
- Effect of Food on the Pharmacokinetics of Saroglitazar Magnesium, a Novel Dual PPARαγ Agonist, in Healthy Adult Subjects Save
- Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers Save
- Pharmacokinetics of Oral ZYAN1 across Indian and Australian Healthy Subjects Save
- A prospective study on drug utilization pattern and rationality in treatment of type II diabetes mellitus: a population based analysis Save